Asensus Surgical Announces Sale of Senhance Robotic System
“We are excited to be partnering with yet another institution to initiate a Senhance program to deliver better patient outcomes,” said
Leveraging the Performance-Guided Surgery™ framework, the Senhance Surgical System advances clinical intelligence by providing surgeons with augmented intelligence and digital tools to perform consistently superior surgery.
Email Alerts: https://ir.asensus.com/email-alerts
This press release includes statements relating to the Senhance Surgical System and the sale of a Senhance System to a distribution partner, which will be ultimately placed at an end user hospital in the Commonwealth of Independent States. These statements and other statements regarding our future plans and goals constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations and include whether the Senhance Surgical System provides the opportunity to revolutionize a surgical team’s capabilities when performing laparoscopic procedures. For a discussion of the risks and uncertainties associated with the Company’s business, please review our filings with the
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/24cd4ee5-138f-47e8-b0b0-fd04ebb2844e
Source: Asensus Surgical, Inc.